Literature DB >> 8450162

Differing patterns of cardiac parasympathetic activity and their evolution in selected patients with a first myocardial infarction.

A D Flapan1, R A Wright, J Nolan, J M Neilson, D J Ewing.   

Abstract

OBJECTIVES: The purpose of the study was to compare cardiac parasympathetic activity during the early and convalescent phases of acute anterior and inferior myocardial infarction.
BACKGROUND: Previous studies have shown that cardiac parasympathetic activity may vary with the site of infarction and that recovery may occur after infarction.
METHODS: Cardiac parasympathetic activity was measured from 24-h electrocardiograms by counting the number of times that successive RR intervals (counts) differed by > 50 ms. Recordings began within 12 h of admission and at 7, 42 and 140 days after acute myocardial infarction in 20 patients (mean age 57 +/- 7.9 years). All patients were treated with streptokinase, aspirin and oral beta-adrenergic blocking agents.
RESULTS: For the entire group, mean total 24-h RR counts increased from 592 (range 78 to 3,812) at 48 h to 648 (range 109 to 5,473) at 7 days, 1,145 (range 162 to 6,268) at 42 days and 1,958 (range 344 to 9,632) at 140 days. Patients with anterior infarction had significantly lower counts (mean 277, range 78 to 2,708; n = 11) compared with those with inferior infarction (mean 2,172, range 897 to 3,812; n = 9) at 48 h (p < 0.05). There was no significant difference in counts between patients with anterior (mean 1,051, range 212 to 6,268) and inferior (mean 1,321, range 162 to 3,265) infarction after 42 or after 140 days (anterior: mean 1,655, range 344 to 9,632; inferior: mean 2,588, range 1,700 to 5,767).
CONCLUSIONS: These data suggest that after anterior myocardial infarction there is impaired cardiac parasympathetic function that improves within 6 weeks, whereas in inferior infarction there is relative preservation of cardiac parasympathetic function.

Entities:  

Mesh:

Year:  1993        PMID: 8450162     DOI: 10.1016/0735-1097(93)90349-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  QT dispersion as a predictor for arrhythmias in patients with acute ST elevation myocardial infarction.

Authors:  Fahad Aziz; Sujatha Doddi; Anshu Alok; Sudheer Penupolu; Vijayant Singh; Michael Benz; Mary Abed
Journal:  J Thorac Dis       Date:  2010-06       Impact factor: 2.895

2.  Lipophilic versus hydrophilic beta(1) blockers and the cardiac sympatho-vagal balance during stress and daily activity in patients after acute myocardial infarction.

Authors:  A Kardos; V Long; J Bryant; J Singh; P Sleight; B Casadei
Journal:  Heart       Date:  1998-02       Impact factor: 5.994

3.  Cardiac parasympathetic activity in severe uncomplicated coronary artery disease.

Authors:  J Nolan; A D Flapan; J Reid; J M Neilson; P Bloomfield; D J Ewing
Journal:  Br Heart J       Date:  1994-06

4.  Preserved parasympathetic cardiac innervation after atrioventricular node modification: evidence from circle maps of respiratory sinus arrhythmia.

Authors:  Markus Zarse; Kai Ulf Markus; Michael Schiek; Patrick Schauerte; Anil Martin Sinha; Friedhelm Drepper; Horst Halling; Peter Hanrath; Christoph Stellbrink
Journal:  J Interv Card Electrophysiol       Date:  2002-10       Impact factor: 1.900

5.  Prediction of cardiac arrest in critically ill patients presenting to the emergency department using a machine learning score incorporating heart rate variability compared with the modified early warning score.

Authors:  Marcus Eng Hock Ong; Christina Hui Lee Ng; Ken Goh; Nan Liu; Zhi Xiong Koh; Nur Shahidah; Tong Tong Zhang; Stephanie Fook-Chong; Zhiping Lin
Journal:  Crit Care       Date:  2012-06-21       Impact factor: 9.097

6.  Time course of changes in heart rate and blood pressure variability in rats with myocardial infarction.

Authors:  R Aires; E B Pimentel; L Forechi; E M Dantas; J G Mill
Journal:  Braz J Med Biol Res       Date:  2017-01-09       Impact factor: 2.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.